2 Jul 2008
High Wycombe, UK – SURGICAL ROBOTICS company Prosurgics has appointed Douglas Le Fort as new Chief Financial Officer.
He joins Prosurgics from Abbott Laboratories, where he was Head of Finance for the international business of Abbott Diabetes Care. Prior to this, he worked at Chiron Corporation, a NASDAQ listed company where he had full fiscal responsibility for the European business. He also held a number of senior finance positions at SC Johnson & Son with fiscal and controllership responsibilities.
“I am extremely excited by this opportunity”, he said. “Prosurgics’ strong management team, its excellent product pipeline and ‘go-to-market’ strategy of cutting-edge but affordable products mean we are extremely well placed to propel the growth of this young company. I am very much looking forward to playing a leadership role in driving Prosurgics into a large and successful international medical devices business.”
Paul Moraviec, Chief Executive of Prosurgics, welcomed his new CFO: “Douglas brings a breadth of technical and commercial experience and valuable strategic insight. With him, our accounting, financial planning, treasury and investor relations reporting will be in excellent hands.”
Last updated: 14 Jul 2009, 11:18 AM
